Rapid and sustained activation of JAK2/STAT3 is closely associated with the onset and progression of HCC and promotes the establishment of the tumor inflammatory microenvironment, which would assist the tumors in attenuating anti‐tumor immune responses, maintaining proliferation, avoiding apoptosis, and accelerating angiogenesis (Zhang et al. 2018). Here, JAK2 is linked to hepatocellular carcinoma.